2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Kidney Cancer
Kidney cancer research has made significant strides, focusing on understanding the genetic and molecular underpinnings of the disease. Studies have identified key mutations and pathways, such as alterations in the VHL gene and the mTOR signaling pathway, which drive cancer progression. This has led to the development of targeted therapies, including tyrosine kinase inhibitors and immune checkpoint inhibitors, which have improved survival rates and outcomes for patients. Ongoing research is exploring combination treatments and personalized medicine approaches to enhance efficacy and reduce side effects. Additionally, advancements in imaging and diagnostic techniques are enabling earlier detection and more precise staging of kidney cancer, further contributing to improved patient management and prognosis.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China